{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:58:49Z","timestamp":1775678329520,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"DOI":"10.1007\/s00702-025-02915-1","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T08:39:30Z","timestamp":1742719170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic innovations for the symptomatic treatment of Parkinson\u2019s disease: focus on technology-based therapies"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8052-4140","authenticated-orcid":false,"given":"Jeryl Ritzi T.","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4578-3777","authenticated-orcid":false,"given":"Avery","family":"Kundrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5330-1263","authenticated-orcid":false,"given":"Enrique C.","family":"Panganiban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7130-7569","authenticated-orcid":false,"given":"Michelle Ann","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6448-4505","authenticated-orcid":false,"given":"Saar","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-5316","authenticated-orcid":false,"given":"Hubert H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"issue":"3","key":"2915_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"JE Ahlskog","year":"2001","unstructured":"Ahlskog JE, Muenter MD (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16(3):448\u2013458. https:\/\/doi.org\/10.1002\/mds.1090","journal-title":"Mov Disord"},{"issue":"6","key":"2915_CR2","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/S40120-023-00533-1","volume":"12","author":"J Aldred","year":"2023","unstructured":"Aldred J et al (2023) Continuous subcutaneous foslevodopa\/foscarbidopa in Parkinson\u2019s disease: safety and efficacy results from a 12-month, single-arm, open-label, phase 3 study\u2019, neurology and therapy. Neurol Ther 12(6):1937\u20131958. https:\/\/doi.org\/10.1007\/S40120-023-00533-1","journal-title":"Neurol Ther"},{"issue":"12","key":"2915_CR3","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1002\/mds.23875","volume":"26","author":"A Antonini","year":"2011","unstructured":"Antonini A et al (2011) Wearing-off scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 26(12):2169\u20132175. https:\/\/doi.org\/10.1002\/mds.23875","journal-title":"Mov Disord"},{"key":"2915_CR65","doi-asserted-by":"publisher","unstructured":"Antonini A, Poewe W, Chaudhuri KR, et al. (2017) Levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s: Final results of the GLORIA registry. Parkinsonism Relat Disord. 45:13\u201320. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2017.09.018","DOI":"10.1016\/J.PARKRELDIS.2017.09.018"},{"issue":"12","key":"2915_CR4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/S40263-022-00963-9","volume":"36","author":"A Antonini","year":"2022","unstructured":"Antonini A et al (2022) Comparative effectiveness of device-aided therapies on quality of life and off-time in advanced Parkinson\u2019s disease: a systematic review and Bayesian network meta-analysis\u2019, CNS drugs. CNS Drugs 36(12):1269\u20131283. https:\/\/doi.org\/10.1007\/S40263-022-00963-9","journal-title":"CNS Drugs"},{"issue":"11","key":"2915_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00702-023-02693-8","volume":"130","author":"A Antonini","year":"2023","unstructured":"Antonini A, D\u2019Onofrio V, Guerra A (2023) Current and novel infusion therapies for patients with Parkinson\u2019s disease. J Neural Transm 130(11):1349\u20131358. https:\/\/doi.org\/10.1007\/s00702-023-02693-8","journal-title":"J Neural Transm"},{"issue":"1","key":"2915_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/nau.24595","volume":"40","author":"TG Araujo","year":"2021","unstructured":"Araujo TG et al (2021) Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson\u2019s disease: a randomized clinical trial\u2019, neurourology and urodynamics. John Wiley Sons Inc 40(1):538\u2013548. https:\/\/doi.org\/10.1002\/nau.24595","journal-title":"John Wiley Sons Inc"},{"issue":"15","key":"2915_CR7","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1017\/S0033291720003670","volume":"50","author":"MJ Begemann","year":"2020","unstructured":"Begemann MJ et al (2020) Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis. Psychol Med 50(15):2465\u20132486. https:\/\/doi.org\/10.1017\/S0033291720003670","journal-title":"Psychol Med"},{"issue":"1","key":"2915_CR8","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/J.PARKRELDIS.2016.11.017","volume":"33","author":"R Bhidayasiri","year":"2016","unstructured":"Bhidayasiri R, Garcia Ruiz PJ, Henriksen T (2016) Practical management of adverse events related to apomorphine therapy\u2019, parkinsonism & related disorders. Parkinsonism Relat Disord 33(1):S42\u2013S48. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2016.11.017","journal-title":"Parkinsonism Relat Disord"},{"key":"2915_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.781488","author":"IV Brak","year":"2022","unstructured":"Brak IV et al (2022) Transcranial current stimulation as a tool of neuromodulation of cognitive functions in Parkinson\u2019s disease. Front NeuroSci 16. https:\/\/doi.org\/10.3389\/fnins.2022.781488","journal-title":"Front NeuroSci"},{"key":"2915_CR10","doi-asserted-by":"publisher","unstructured":"Brillman S et al (2023) Non-Invasive transcutaneous afferent patterned stimulation therapy offers action tremor relief in Parkinson\u2019s disease\u2019, tremor and other hyperkinetic movements. Cent Digit Res Scholarsh 13(1). https:\/\/doi.org\/10.5334\/tohm.762","DOI":"10.5334\/tohm.762"},{"key":"2915_CR11","doi-asserted-by":"publisher","unstructured":"Burack M, et al (2018) \u2018Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners\u2019, Movement Disorders Clinical Practice. John Wiley & Sons, Ltd, 5(4):383\u2013393. https:\/\/doi.org\/10.1002\/MDC3.12630","DOI":"10.1002\/MDC3.12630"},{"key":"2915_CR12","doi-asserted-by":"publisher","unstructured":"Cakmak YO et al (2017) Rapid alleviation of Parkinson\u2019s disease symptoms via electrostimulation of intrinsic auricular muscle zones. Front Hum Neurosci Front Media S A 11. https:\/\/doi.org\/10.3389\/fnhum.2017.00338","DOI":"10.3389\/fnhum.2017.00338"},{"key":"2915_CR13","doi-asserted-by":"publisher","unstructured":"Cakmak YO et al (2020) Intrinsic auricular muscle zone stimulation improves walking parameters of Parkinson\u2019s patients faster than Levodopa in the motion capture analysis: a pilot study\u2019, frontiers in neurology. Front Media S A 11. https:\/\/doi.org\/10.3389\/fneur.2020.546123","DOI":"10.3389\/fneur.2020.546123"},{"issue":"5","key":"2915_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3233\/JPD-225105","volume":"13","author":"KR Chaudhuri","year":"2023","unstructured":"Chaudhuri KR et al (2023) Levodopa carbidopa intestinal gel in advanced Parkinson\u2019s disease: DUOGLOBE final 3-year results\u2019, Journal of Parkinson\u2019s disease. J Parkinsons Dis 13(5):769\u2013783. https:\/\/doi.org\/10.3233\/JPD-225105","journal-title":"J Parkinsons Dis"},{"issue":"7","key":"2915_CR15","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s10072-020-04884-7","volume":"42","author":"A Dincher","year":"2021","unstructured":"Dincher A, Becker P, Wydra G (2021) Effect of whole-body vibration on freezing and flexibility in Parkinson\u2019s disease\u2014a pilot study\u2019, neurological sciences. Springer-Verlag Italia S R L 42(7):2795\u20132801. https:\/\/doi.org\/10.1007\/s10072-020-04884-7","journal-title":"Springer-Verlag Italia S R L"},{"issue":"10","key":"2915_CR16","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/brain\/awz261","volume":"142","author":"MF Dirkx","year":"2019","unstructured":"Dirkx MF et al (2019) Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson\u2019s tremor. Brain 142(10):3144\u20133157. https:\/\/doi.org\/10.1093\/brain\/awz261","journal-title":"Brain"},{"key":"2915_CR17","doi-asserted-by":"publisher","unstructured":"Ellenbogen A et al (2023) Safety and efficacy of continuous subcutaneous levodopa\/carbidopa infusion for Parkinson\u2019s disease: three-year data from the open-label beyond study (PL4.003)\u2019, neurology. Ovid technologies (Wolters Kluwer Health), 100(17_supplement_2). https:\/\/doi.org\/10.1212\/WNL.0000000000202964","DOI":"10.1212\/WNL.0000000000202964"},{"issue":"5","key":"2915_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(24)00052-8","volume":"23","author":"AJ Espay","year":"2024","unstructured":"Espay AJ et al (2024) Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson\u2019s disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial\u2019, the lancet. Neurol Lancet Neurol 23(5):465\u2013476. https:\/\/doi.org\/10.1016\/S1474-4422(24)00052-8","journal-title":"Neurol Lancet Neurol"},{"issue":"1","key":"2915_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","volume":"991","author":"S FAHN","year":"2003","unstructured":"FAHN S (2003) Description of Parkinson\u2019s disease as a clinical syndrome. Ann N Y Acad Sci 991(1):1\u201314. https:\/\/doi.org\/10.1111\/j.1749-6632.2003.tb07458.x","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2915_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/J.PARKRELDIS.2012.11.020","volume":"19","author":"HH Fernandez","year":"2013","unstructured":"Fernandez HH et al (2013) Levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease open-label study: interim results\u2019, parkinsonism & related disorders. Parkinsonism Relat Disord 19(3):339\u2013345. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2012.11.020","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"2915_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/MDS.26123","volume":"30","author":"HH Fernandez","year":"2014","unstructured":"Fernandez HH et al (2014) Levodopa-carbidopa intestinal gel in advanced Parkinson\u2019d disease: final 12-month, open-label results\u2019, movement disorders. John Wiley Sons Inc 30(4):500. https:\/\/doi.org\/10.1002\/MDS.26123","journal-title":"John Wiley Sons Inc"},{"issue":"6","key":"2915_CR22","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/MDS.27338","volume":"33","author":"HH Fernandez","year":"2018","unstructured":"Fernandez HH et al (2018) Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc Mov Disord 33(6):928\u2013936. https:\/\/doi.org\/10.1002\/MDS.27338","journal-title":"Mov Disorders: Official J Mov Disorder Soc Mov Disord"},{"key":"2915_CR23","doi-asserted-by":"publisher","unstructured":"Fernandez HH et al (2024) Intrinsic auricular muscle zone stimulation for Parkinson disease: the EARSTIM-PD phase II multi-center pilot study results\u2019, parkinsonism and related disorders. Elsevier Ltd, p 121. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105959","DOI":"10.1016\/j.parkreldis.2023.105959"},{"issue":"4","key":"2915_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/nau.20651","volume":"28","author":"E Finazzi-Agr\u00f2","year":"2009","unstructured":"Finazzi-Agr\u00f2 E et al (2009) Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials. Neurourol Urodyn 28(4):320\u2013324. https:\/\/doi.org\/10.1002\/nau.20651","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"2915_CR25","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1002\/MDS.28703","volume":"36","author":"E Freire-Alvarez","year":"2021","unstructured":"Freire-Alvarez E et al (2021) Levodopa-carbidopa intestinal gel reduces dyskinesia in Parkinson\u2019s disease in a randomized trial. Mov Disorders: Official J Mov Disorder Soc Mov Disord 36(11):2615\u20132623. https:\/\/doi.org\/10.1002\/MDS.28703","journal-title":"Mov Disorders: Official J Mov Disorder Soc Mov Disord"},{"key":"2915_CR26","doi-asserted-by":"publisher","unstructured":"Haas CT et al (2006) The effects of random whole-body-vibration on motor symptoms in Parkinson\u2019s disease. 21(1):29\u201336. https:\/\/doi.org\/10.3233\/NRE-2006-21105","DOI":"10.3233\/NRE-2006-21105"},{"issue":"2","key":"2915_CR27","first-page":"1079","volume":"5","author":"M Heesterbeek","year":"2017","unstructured":"Heesterbeek M et al (2017) Whole body vibration enhances choline acetyltransferase-immuno-reactivity in cortex and amygdala. J Neurol Transl Neurosci 5(2):1079","journal-title":"J Neurol Transl Neurosci"},{"key":"2915_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jns.2017.08.3246","volume":"381","author":"O Jitkritsadakul","year":"2017","unstructured":"Jitkritsadakul O et al (2017) Tremor\u2019s glove-an innovative electrical muscle stimulation therapy for intractable tremor in Parkinson\u2019s disease: a randomized sham-controlled trial. J Neurol Sci Elsevier B V 381:331\u2013340. https:\/\/doi.org\/10.1016\/j.jns.2017.08.3246","journal-title":"J Neurol Sci Elsevier B V"},{"issue":"9","key":"2915_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1474-4422(18)30239-4","volume":"17","author":"R Katzenschlager","year":"2018","unstructured":"Katzenschlager R et al (2018) Apomorphine subcutaneous infusion in patients with Parkinson\u2019s disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol ELSEVIER Sci INC 17(9):749\u2013759. https:\/\/doi.org\/10.1016\/S1474-4422(18)30239-4","journal-title":"Lancet Neurol ELSEVIER Sci INC"},{"key":"2915_CR31","doi-asserted-by":"publisher","unstructured":"Lench DH et al (2023) Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson\u2019s disease: evaluating feasibility, safety, and preliminary efficacy. Front Neurol Front Media SA 14. https:\/\/doi.org\/10.3389\/fneur.2023.1210103","DOI":"10.3389\/fneur.2023.1210103"},{"issue":"1","key":"2915_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.26082","volume":"30","author":"PA LeWitt","year":"2015","unstructured":"LeWitt PA (2015) Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics. Mov Disord 30(1):64\u201372. https:\/\/doi.org\/10.1002\/mds.26082","journal-title":"Mov Disord"},{"key":"2915_CR66","doi-asserted-by":"publisher","unstructured":"Li K, Cho Y, Chen R (2021) The effect of whole-body vibration on proprioception and motor function for individuals with moderate Parkinson disease: a single-blind randomized controlled trial. Occup Ther Int. 2021:1\u20139. https:\/\/doi.org\/10.1155\/2021\/9441366","DOI":"10.1155\/2021\/9441366"},{"issue":"9","key":"2915_CR33","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1007\/S00415-019-09337-6","volume":"266","author":"L Lopiano","year":"2019","unstructured":"Lopiano L et al (2019) Motor and non-motor outcomes in patients with advanced Parkinson\u2019s disease treated with levodopa\/carbidopa intestinal gel: final results of the GREENFIELD observational study. J Neurol J Neurol 266(9):2164\u20132176. https:\/\/doi.org\/10.1007\/S00415-019-09337-6","journal-title":"J Neurol J Neurol"},{"issue":"3","key":"2915_CR34","doi-asserted-by":"publisher","first-page":"e00310","DOI":"10.1016\/j.neurot.2023.e00310","volume":"21","author":"AE Martinez-Nunez","year":"2024","unstructured":"Martinez-Nunez AE et al (2024) Emerging therapies for neuromodulation in Parkinson\u2019s disease. Neurotherapeutics 21(3):e00310. https:\/\/doi.org\/10.1016\/j.neurot.2023.e00310","journal-title":"Neurotherapeutics"},{"key":"2915_CR35","doi-asserted-by":"publisher","unstructured":"McClurg D et al (2022) Stimulation of the tibial nerve-a randomised trial for urinary problems associated with Parkinson\u2019s-the STARTUP trial. Age and ageing, vol 51. Oxford University Press, 6 https:\/\/doi.org\/10.1093\/ageing\/afac114","DOI":"10.1093\/ageing\/afac114"},{"issue":"6","key":"2915_CR36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","volume":"101","author":"MM McGregor","year":"2019","unstructured":"McGregor MM, Nelson AB (2019) Circuit mechanisms of Parkinson\u2019s disease. Neuron 101(6):1042\u20131056. https:\/\/doi.org\/10.1016\/j.neuron.2019.03.004","journal-title":"Neuron"},{"key":"2915_CR37","doi-asserted-by":"publisher","unstructured":"Menekseoglu AK (2023) Acute effect of transcutaneous auricular vagus nerve stimulation on hand tremor in Parkinson\u2019s disease: a pilot study of case series\u2019, SiSli Etfal hastanesi tip Bulteni \/ the medical bulletin of Sisli hospital. Kare Publishing, pp 513\u2013519. https:\/\/doi.org\/10.14744\/semb.2023.77200","DOI":"10.14744\/semb.2023.77200"},{"key":"2915_CR38","doi-asserted-by":"publisher","unstructured":"Morris R et al (2019) Noninvasive vagus nerve stimulation to target gait impairment in Parkinson\u2019s disease\u2019, movement disorders. John Wiley and Sons Inc., pp 918\u2013919. https:\/\/doi.org\/10.1002\/mds.27664","DOI":"10.1002\/mds.27664"},{"issue":"17","key":"2915_CR39","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.3390\/jcm12175448","volume":"12","author":"K Muksuris","year":"2023","unstructured":"Muksuris K et al (2023) Noninvasive neuromodulation in Parkinson\u2019s disease: insights from animal models. J Clin Med 12(17):5448. https:\/\/doi.org\/10.3390\/jcm12175448","journal-title":"J Clin Med"},{"key":"2915_CR40","doi-asserted-by":"publisher","unstructured":"Nyholm D, Jost WH (2022) Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson\u2019s disease: real-world experience and practical guidance\u2019, therapeutic advances in neurological disorders. Ther Adv Neurol Disord 15. https:\/\/doi.org\/10.1177\/17562864221108018","DOI":"10.1177\/17562864221108018"},{"key":"2915_CR41","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","volume":"23","author":"JA Obeso","year":"2000","unstructured":"Obeso JA, Olanow CW, Nutt JG (2000) Levodopa motor complications in Parkinson\u2019s disease. Trends Neurosci 23:S2\u2013S7. https:\/\/doi.org\/10.1016\/S1471-1931(00)00031-8","journal-title":"Trends Neurosci"},{"issue":"7","key":"2915_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/WNR.0000000000000360","volume":"26","author":"Y Okada","year":"2015","unstructured":"Okada Y et al (2015) Galvanic vestibular stimulation may improve anterior bending posture in Parkinson\u2019s disease\u2019, neuroreport. Lippincott Williams Wilkins 26(7):405\u2013410. https:\/\/doi.org\/10.1097\/WNR.0000000000000360","journal-title":"Lippincott Williams Wilkins"},{"issue":"2","key":"2915_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","volume":"13","author":"CW Olanow","year":"2013","unstructured":"Olanow CW et al (2013) Double-blind, double-dummy, randomized study of continuous intrajejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease. Lancet Neurol 13(2):141. https:\/\/doi.org\/10.1016\/S1474-4422(13)70293-X","journal-title":"Lancet Neurol"},{"issue":"3","key":"2915_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/ane.13253","volume":"142","author":"AS Pagnussat","year":"2020","unstructured":"Pagnussat AS et al (2020) Plantar stimulation alters brain connectivity in idiopathic Parkinson\u2019s disease. Acta Neurol Scand Blackwell Publishing Ltd 142(3):229\u2013238. https:\/\/doi.org\/10.1111\/ane.13253","journal-title":"Acta Neurol Scand Blackwell Publishing Ltd"},{"issue":"1","key":"2915_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/WON.0000000000000078","volume":"42","author":"MC Perissinotto","year":"2015","unstructured":"Perissinotto MC et al (2015) Transcutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms and its impact on health-related quality of life in patients with Parkinson disease: a randomized controlled trial\u2019, journal of wound, ostomy and continence nursing. Lippincott Williams Wilkins 42(1):94\u201399. https:\/\/doi.org\/10.1097\/WON.0000000000000078","journal-title":"Lippincott Williams Wilkins"},{"issue":"8","key":"2915_CR46","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1007\/s00415-024-12504-z","volume":"271","author":"D Peto","year":"2024","unstructured":"Peto D et al (2024) No evidence for effects of low-intensity vestibular noise stimulation on mild-to-moderate gait impairments in patients with Parkinson\u2019s disease. J Neurol 271(8):5489\u20135497. https:\/\/doi.org\/10.1007\/s00415-024-12504-z","journal-title":"J Neurol"},{"key":"2915_CR47","doi-asserted-by":"publisher","unstructured":"Pfeifer KJ et al (2021) Coordinated reset vibrotactile stimulation induces sustained cumulative benefits in Parkinson\u2019s disease. Front Physiol Front Media S A 12. https:\/\/doi.org\/10.3389\/fphys.2021.624317","DOI":"10.3389\/fphys.2021.624317"},{"key":"2915_CR48","doi-asserted-by":"publisher","unstructured":"Phuenpathom W et al (2022) Vibratory and plantar pressure stimulation: steps to improve freezing of gait in Parkinson\u2019s disease\u2019, parkinsonism and related disorders, vol 105. Elsevier Ltd, pp 43\u201351. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.10.024","DOI":"10.1016\/j.parkreldis.2022.10.024"},{"key":"2915_CR49","unstructured":"Prescribing Information (no date) (2024) Available at: https:\/\/www.abbviepro.com\/ie\/en\/neuroscience\/neurology\/products\/produodopa\/prescribing-information.html (Accessed: 30 December"},{"issue":"9","key":"2915_CR50","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/MDS.29160","volume":"37","author":"R Rajan","year":"2022","unstructured":"Rajan R et al (2022) Device-assisted and neuromodulatory therapies for Parkinson\u2019s disease: a network meta-analysis\u2019, movement disorders: official journal of the movement disorder society. Mov Disord 37(9):1785\u20131797. https:\/\/doi.org\/10.1002\/MDS.29160","journal-title":"Mov Disord"},{"issue":"S3","key":"2915_CR51","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.10513","volume":"53","author":"O Rascol","year":"2003","unstructured":"Rascol O et al (2003) Limitations of current Parkinson\u2019s disease therapy. Ann Neurol 53(S3):S3\u2013S15. https:\/\/doi.org\/10.1002\/ana.10513","journal-title":"Ann Neurol"},{"issue":"3","key":"2915_CR52","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.brs.2014.11.019","volume":"8","author":"G Samoudi","year":"2015","unstructured":"Samoudi G et al (2015) Effects of stochastic vestibular galvanic stimulation and LDOPA on balance and motor symptoms in patients with Parkinson\u2019s disease. Brain Stimul 8(3):474\u2013480. https:\/\/doi.org\/10.1016\/j.brs.2014.11.019","journal-title":"Brain Stimul"},{"issue":"2","key":"2915_CR53","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/MDS.26855","volume":"32","author":"M Senek","year":"2017","unstructured":"Senek M, Nielsen EI, Nyholm D (2017) Levodopa-entacapone-carbidopa intestinal gel in Parkinson\u2019s disease: a randomized crossover study\u2019, movement disorders: official journal of the movement disorder society. Mov Disord 32(2):283\u2013286. https:\/\/doi.org\/10.1002\/MDS.26855","journal-title":"Mov Disord"},{"issue":"11","key":"2915_CR54","doi-asserted-by":"publisher","first-page":"E222","DOI":"10.1111\/aor.13059","volume":"41","author":"B Sijobert","year":"2017","unstructured":"Sijobert B et al (2017) Effects of sensitive electrical stimulation-based somatosensory cueing in Parkinson\u2019s disease gait and freezing of gait assessment. Artif Organs 41(11):E222\u2013E232. https:\/\/doi.org\/10.1111\/aor.13059","journal-title":"Artif Organs"},{"issue":"12","key":"2915_CR55","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1474-4422(22)00400-8","volume":"21","author":"MJ Soileau","year":"2022","unstructured":"Soileau MJ et al (2022) Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson\u2019s disease: a randomised, double-blind, active-controlled, phase 3 trial\u2019, the lancet. Neurol Lancet Neurol 21(12):1099\u20131109. https:\/\/doi.org\/10.1016\/S1474-4422(22)00400-8","journal-title":"Neurol Lancet Neurol"},{"issue":"3","key":"2915_CR56","doi-asserted-by":"publisher","first-page":"E209","DOI":"10.1097\/MJT.0000000000001707","volume":"31","author":"JA Sz\u00e1sz","year":"2024","unstructured":"Sz\u00e1sz JA et al (2024) Levodopa-carbidopa-entacapone intestinal gel in advanced Parkinson disease: a multicenter real-life experience\u2019, American journal of therapeutics. Am J Ther 31(3):E209\u2013E218. https:\/\/doi.org\/10.1097\/MJT.0000000000001707","journal-title":"Am J Ther"},{"issue":"4","key":"2915_CR57","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/0269215520972519","volume":"35","author":"PN Taylor","year":"2021","unstructured":"Taylor PN et al (2021) The effectiveness of peroneal nerve functional electrical simulation for the reduction of bradykinesia in Parkinson\u2019s disease: a feasibility study for a randomised control trial\u2019, clinical rehabilitation. SAGE Publications Ltd 35(4):546\u2013557. https:\/\/doi.org\/10.1177\/0269215520972519","journal-title":"SAGE Publications Ltd"},{"key":"2915_CR58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/BS.IRN.2017.03.001","volume":"132","author":"J Timpka","year":"2017","unstructured":"Timpka J et al (2017) Device-aided treatment strategies in advanced Parkinson\u2019s disease\u2019, international review of neurobiology. Int Rev Neurobiol 132:453\u2013474. https:\/\/doi.org\/10.1016\/BS.IRN.2017.03.001","journal-title":"Int Rev Neurobiol"},{"issue":"7","key":"2915_CR59","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.acuro.2017.01.009","volume":"41","author":"C Valles-Antu\u00f1a","year":"2017","unstructured":"Valles-Antu\u00f1a C et al (2017) Estimulaci\u00f3n transcut\u00e1nea Del nervio tibial posterior En El Tratamiento de La incontinencia urinaria de Urgencia refractaria, de Origen idiop\u00e1tico y neur\u00f3genico. Actas Urol\u00f3gicas Espa\u00f1olas 41(7):465\u2013470. https:\/\/doi.org\/10.1016\/j.acuro.2017.01.009","journal-title":"Actas Urol\u00f3gicas Espa\u00f1olas"},{"issue":"5","key":"2915_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3233\/JPD-225112","volume":"13","author":"T van Laar","year":"2023","unstructured":"van Laar T et al (2023) Infusion therapies in the treatment of Parkinson\u2019s disease. J Parkinson\u2019s Disease 13(5):641\u2013657. https:\/\/doi.org\/10.3233\/JPD-225112","journal-title":"J Parkinson\u2019s Disease"},{"issue":"2","key":"2915_CR60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/MDC3.13926","volume":"11","author":"V Viljaharju","year":"2024","unstructured":"Viljaharju V et al (2024) Levodopa-entacapone-carbidopa intestinal gel treatment in advanced Parkinson\u2019s disease: a single-center study of 30 patients\u2019, movement disorders clinical practice. Mov Disord Clin Pract 11(2):159\u2013165. https:\/\/doi.org\/10.1002\/MDC3.13926","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"2915_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3233\/NRE-161308","volume":"38","author":"D Wilkinson","year":"2016","unstructured":"Wilkinson D, Podlewska A, Sakel M (2016) A durable gain in motor and non-motor symptoms of Parkinson\u2019s disease following repeated caloric vestibular stimulation: a single-case study\u2019, neurorehabilitation: an international. Interdisciplinary J 38(2):179\u2013182. https:\/\/doi.org\/10.3233\/NRE-161308","journal-title":"Interdisciplinary J"},{"key":"2915_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.parkreldis.2019.05.031","volume":"65","author":"D Wilkinson","year":"2019","unstructured":"Wilkinson D et al (2019) Caloric vestibular stimulation for the management of motor and non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 65:261\u2013266. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.031","journal-title":"Parkinsonism Relat Disord"},{"issue":"14","key":"2915_CR63","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1002\/mds.23932","volume":"26","author":"A Yarnall","year":"2011","unstructured":"Yarnall A, Rochester L, Burn DJ (2011) The interplay of cholinergic function, attention, and falls in Parkinson\u2019s disease. Mov Disord 26(14):2496\u20132503. https:\/\/doi.org\/10.1002\/mds.23932","journal-title":"Mov Disord"},{"issue":"12","key":"2915_CR64","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1111\/cns.14309","volume":"29","author":"H Zhang","year":"2023","unstructured":"Zhang H et al (2023) Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson\u2019s disease: a pilot randomized study\u2019, CNS neuroscience and therapeutics. John Wiley Sons Inc 29(12):3889\u20133900. https:\/\/doi.org\/10.1111\/cns.14309","journal-title":"John Wiley Sons Inc"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02915-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02915-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02915-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T08:39:47Z","timestamp":1742719187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02915-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":66,"alternative-id":["2915"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02915-1","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}